Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Tobradex vs Generic Tobramycin/Dexamethasone in Blepharoconjunctivitis
NCT03975374Phase 1Unknown
- Sponsor
- Sutphin Drugs
- Start
- Jun 2019
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of tobramycin and dexamethasone in blepharoconjunctivitis (2 arms), sponsored by Sutphin Drugs. Primary endpoint: Sign and symptoms composite score at 10 days. Status: unknown.
02
Drugs
tobramycindexamethasone
03
Conditions
blepharoconjunctivitis
Beyond the preview
Go deeper on NCT03975374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03975374.